PT1165042E - Suspensao farmaceutica bebivel de ibuprofeno - Google Patents

Suspensao farmaceutica bebivel de ibuprofeno

Info

Publication number
PT1165042E
PT1165042E PT00917139T PT00917139T PT1165042E PT 1165042 E PT1165042 E PT 1165042E PT 00917139 T PT00917139 T PT 00917139T PT 00917139 T PT00917139 T PT 00917139T PT 1165042 E PT1165042 E PT 1165042E
Authority
PT
Portugal
Prior art keywords
ibuprofen
beverage
pharmaceutical suspension
suspension
weight
Prior art date
Application number
PT00917139T
Other languages
English (en)
Inventor
Pascal Suplie
Lebon Christophe
Guerin Emmanuel
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9904251A external-priority patent/FR2791888B1/fr
Priority claimed from FR0004359A external-priority patent/FR2791889B1/fr
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of PT1165042E publication Critical patent/PT1165042E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
PT00917139T 1999-04-06 2000-04-06 Suspensao farmaceutica bebivel de ibuprofeno PT1165042E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904251A FR2791888B1 (fr) 1999-04-06 1999-04-06 Suspension pharmaceutique buvable
FR0004359A FR2791889B1 (fr) 2000-04-05 2000-04-05 Suspension pharmaceutique buvable d'ibuprofene

Publications (1)

Publication Number Publication Date
PT1165042E true PT1165042E (pt) 2005-06-30

Family

ID=26212324

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00917139T PT1165042E (pt) 1999-04-06 2000-04-06 Suspensao farmaceutica bebivel de ibuprofeno

Country Status (10)

Country Link
US (1) US6794411B1 (pt)
EP (1) EP1165042B1 (pt)
CN (1) CN1190185C (pt)
AT (1) ATE288257T1 (pt)
AU (1) AU771516B2 (pt)
BR (1) BR0009557A (pt)
DE (1) DE60017881T2 (pt)
ES (1) ES2234581T3 (pt)
PT (1) PT1165042E (pt)
WO (1) WO2000059467A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002327418A1 (en) * 2001-08-01 2003-02-17 Bristol-Myers Squibb Company Taste masking composition
CN1655762B (zh) * 2002-06-17 2010-05-26 塔罗制药美国公司 布洛芬混悬剂
ATE534371T1 (de) * 2003-02-06 2011-12-15 Gebro Pharma Gmbh Pharmazeutische zubereitungen und verfahren zu deren herstellung
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
DE102007052071A1 (de) * 2007-10-30 2009-05-07 Stada Arzneimittel Ag Stabilisiertes Atorvastatin
JP5977672B2 (ja) * 2009-04-27 2016-08-24 ラボラトリオ デ アプリカシオネス ファルマコディナミカス，エセ．アー．Ｌａｂｏｒａｔｏｒｉｏ Ｄｅ Ａｐｌｉｃａｃｉｏｎｅｓ Ｆａｒｍａｃｏｄｉｎａｍｉｃａｓ，Ｓ．Ａ． イブプロフェンリシナートの経口投与用の懸濁液
CN102204882B (zh) * 2011-03-22 2013-07-24 韩彬 布洛芬的药物组合物
AU2015311674B2 (en) 2014-09-05 2018-03-08 Lupin Inc. Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210785A (en) 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
NL193682C (nl) 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4788220A (en) 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
DE3900811A1 (de) 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh Neue arzneiform
NZ234143A (en) 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
IE902829A1 (en) 1989-08-14 1991-02-27 Eurand America Microencapsulated taste-masked water-insoluble nsaid drug¹materials
JP2879905B2 (ja) 1989-08-28 1999-04-05 武田薬品工業株式会社 イブプロフェン含有経口投与用組成物
DE69109282T2 (de) 1990-04-11 1995-09-28 Upjohn Co Verfahren zum geschmacksabdecken von ibuprofen.
IT1246383B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
JP2814138B2 (ja) * 1990-07-23 1998-10-22 エスエス製薬株式会社 懸濁シロップ剤
US5110606A (en) 1990-11-13 1992-05-05 Affinity Biotech, Inc. Non-aqueous microemulsions for drug delivery
IL104093A (en) 1991-12-31 1999-06-20 Abbott Lab Prolamine is expected to mask the taste of drugs given orally
US5272137A (en) 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
AU670567B2 (en) * 1992-03-05 1996-07-25 American Home Products Corporation Pharmaceutical coated cores
CA2143439A1 (en) 1992-09-03 1994-03-17 Seang H. Yiv Taste-masking pharmaceutical compostiions and methods for making the same
WO1994008576A1 (en) 1992-10-16 1994-04-28 Glaxo Group Limited Taste-masking compositions of ranitidine
GB9224855D0 (en) 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
WO1994025006A1 (en) 1993-04-26 1994-11-10 Affinity Biotech, Inc. Taste-masking pharmaceutical compositions and methods for making the same
ZA945944B (en) 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
FR2713931B1 (fr) * 1993-12-20 1996-04-05 Laurence Paris Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation.
US5925376C1 (en) * 1994-01-10 2001-03-20 Madalene C Y Heng Method for treating psoriasis using selected phosphorylase kinase inhibitor and additional compounds
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
EP0717992A3 (en) 1994-12-21 1998-03-25 McNEIL-PPC, INC. Aqueous suspension formulations for pharmaceutical applications
US5560913A (en) 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5563177A (en) 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids
WO1996035436A1 (en) 1995-05-09 1996-11-14 The Procter & Gamble Company Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders
GB2318511A (en) 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
JPH10182449A (ja) 1996-12-25 1998-07-07 Kobayashi Seiyaku Kogyo Kk 易嚥下性イブプロフェン含有製剤
FR2771292B1 (fr) 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
FR2771291B1 (fr) 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques

Also Published As

Publication number Publication date
CN1352548A (zh) 2002-06-05
AU3825100A (en) 2000-10-23
DE60017881T2 (de) 2006-04-13
EP1165042A1 (fr) 2002-01-02
ATE288257T1 (de) 2005-02-15
AU771516B2 (en) 2004-03-25
DE60017881D1 (de) 2005-03-10
EP1165042B1 (fr) 2005-02-02
US6794411B1 (en) 2004-09-21
ES2234581T3 (es) 2005-07-01
BR0009557A (pt) 2002-05-28
WO2000059467A1 (fr) 2000-10-12
CN1190185C (zh) 2005-02-23

Similar Documents

Publication Publication Date Title
IL150986A0 (en) 1,2,3,4,- tetrahydroisoquinoline derivatives
DZ3165A1 (fr) Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
FR2789079B3 (fr) Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
MY129150A (en) Novel sulfamides
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
NO994621D0 (no) Ernaeringsformuleringer inneholdende oligosakkarider
CA2292673A1 (en) Pharmaceutical compositions containing eletriptan hemisulphate
IL149163A0 (en) Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them
CA2361402A1 (en) Bis-sulfonamides
ITMI931452A0 (it) Flacone per la conservazione in condizione separata di sostanze da miscelarsi prima dell'erogazione
GB9920281D0 (en) Novel compositions of biologically active agents and their use
PT1165042E (pt) Suspensao farmaceutica bebivel de ibuprofeno
WO1999006388A8 (en) Pharmaceutical compounds isolated from aristolochia taliscana
BE1014502A5 (fr) Compositions pharmaceutiques.
WO1994019343A3 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
DE59610175D1 (de) Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe
AU4431400A (en) Anticancer agents containing ep1 antagonists as the active ingredient
MY140724A (en) Novel arylethene-sulfonamides
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
IT1250672B (it) Formulazioni orali di ubidecarenone in soluzione acquosa
BG103306A (en) Liquid allendronate compositions
ES2197781A1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
YU87501A (sh) Farmaceutski kompleksi
MXPA02012015A (es) Ligandos de receptores para integrinas.
BRPI0411186B1 (pt) composição de sabão líquido transparente e seu processo de preparação